The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study (MIND-USA)
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Sponsor: Vanderbilt University Medical Center
Listed as NCT01211522, this PHASE3 trial focuses on Delirium and Impaired Cognition and remains completed. Sponsored by Vanderbilt University Medical Center, it has been updated 14 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 9 earlier versions
-
Oct 2019 — Dec 2019 [monthly]
Completed PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jul 2017 — Mar 2018 [monthly]
Recruiting PHASE3
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .